Hangzhou Wensli Silk Culture
301066
Yoantion Industrial Inc.,
301053
Xinlei Compressor
301317
4
QIFENG
873169
5
LAISAI LASER
871263
CN Stock MarketDetailed Quotes
600713 Nanjing Pharmaceutical
- 5.12
- -0.05-0.97%
Market Closed May 9 15:00 CST
6.70BMarket Cap11.38P/E (TTM)
5.18High5.11Low108.28KlotVolume5.16Open5.17Pre Close55.66MTurnover0.83%Turnover Ratio11.74P/E (Static)1.31BShares5.6452wk High0.96P/B6.67BFloat Cap4.0652wk Low5.69Limit Up1.30BShs Float19.62Historical High4.65Limit Down1.35%Amplitude-0.27Historical Low0.16Dividend TTM5.14Avg Price58.59KlotAsk3.13%Div YieldTTM100Lot Size47.32KlotBid
Nanjing Pharmaceutical Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 2.11%14.25B | 0.20%53.7B | 0.97%40.94B | -0.41%27.23B | -0.92%13.95B | 6.71%53.59B | 8.31%40.55B | 14.21%27.34B | 20.35%14.08B | 11.30%50.22B |
| Operating revenue | 2.11%14.25B | 0.20%53.7B | 0.97%40.94B | -0.41%27.23B | -0.92%13.95B | 6.71%53.59B | 8.31%40.55B | 14.21%27.34B | 20.35%14.08B | 11.30%50.22B |
| Other operating revenue | ---- | 10.11%128.05M | ---- | 44.29%60.72M | ---- | -21.15%116.29M | ---- | -43.56%42.08M | ---- | -7.30%147.48M |
| Total operating cost | 2.05%13.94B | 0.01%52.65B | 0.79%40.12B | -0.65%26.67B | -1.15%13.66B | 7.03%52.65B | 8.59%39.81B | 14.72%26.84B | 20.73%13.82B | 11.16%49.19B |
| Operating cost | 2.18%13.4B | 0.09%50.32B | 0.87%38.41B | -0.60%25.55B | -1.18%13.11B | 7.06%50.28B | 8.57%38.08B | 14.84%25.71B | 20.93%13.27B | 11.32%46.96B |
| Operating tax surcharges | 13.06%28.77M | 8.07%116.27M | 15.75%85.32M | 22.99%54.79M | 23.25%25.45M | -7.69%107.59M | -11.87%73.71M | -16.41%44.55M | 16.84%20.65M | 27.57%116.55M |
| Operating expense | 3.55%291.36M | -2.13%1.15B | -1.50%845.97M | -1.63%557.87M | -2.28%281.36M | 1.34%1.17B | 3.83%858.87M | 8.22%567.14M | 15.11%287.92M | 7.58%1.16B |
| Administration expense | -3.47%98.42M | 0.04%517.66M | -4.29%346.18M | -12.25%209.42M | -8.18%101.96M | 6.24%517.44M | 8.81%361.69M | 8.70%238.65M | 6.84%111.04M | 12.50%487.05M |
| Financial expense | -10.40%118.15M | -3.58%515.59M | -0.11%400.55M | 0.71%269.71M | 4.55%131.87M | 22.88%534.75M | 26.60%400.98M | 32.04%267.79M | 25.47%126.13M | -1.51%435.17M |
| -Interest expense (Financial expense) | -21.80%69.47M | -13.92%325.82M | -7.64%266.51M | -9.63%170.53M | -3.64%88.83M | 13.70%378.49M | 14.72%288.55M | 15.10%188.7M | 5.86%92.19M | -12.44%332.9M |
| -Interest Income (Financial expense) | -52.64%-6.07M | -34.24%-13.61M | -23.89%-10.17M | -29.66%-6.4M | -3.24%-3.98M | 11.16%-10.14M | 23.15%-8.21M | 27.17%-4.93M | 16.74%-3.85M | 13.38%-11.41M |
| Research and development | -10.92%9.12M | -15.35%30.64M | 7.12%30.54M | 24.52%22.29M | 22.30%10.23M | 31.91%36.19M | 30.25%28.51M | 32.68%17.9M | 69.19%8.37M | 30.90%27.43M |
| Credit Impairment Loss | -15.10%-41.74M | -317.36%-41.93M | -234.86%-68.81M | -449.11%-33.85M | -186.99%-36.26M | 119.62%19.29M | 66.47%-20.55M | 123.77%9.7M | 65.25%-12.64M | -1,131.86%-98.33M |
| Asset Impairment Loss | 563.29%2.16M | -192.35%-18.27M | 46.13%-2.12M | -45.68%-4.92M | -139.08%-467.14K | 7.72%-6.25M | -2,580.78%-3.94M | -2,761.32%-3.38M | -363.15%-195.39K | 21.42%-6.77M |
| Other net revenue | -8.72%-28.57M | -133.83%-21.38M | -388.91%-43.48M | -156.90%-19.64M | -247.88%-26.28M | 162.58%63.22M | 120.37%15.05M | 152.66%34.51M | 80.60%-7.55M | -256.68%-101.02M |
| Fair value change income | --353.89K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Invest income | 69.59%178.68K | -53.17%4.02M | -64.44%3.1M | -73.79%1.04M | 114.08%105.36K | 117.64%8.58M | 117.85%8.71M | 107.71%3.96M | 96.87%-748.43K | 44.56%-48.64M |
| -Including: Investment income associates | -692.50%-512.28K | -90.34%585.28K | -82.96%1.07M | -78.58%834.34K | 91.36%-64.64K | 1,267.85%6.06M | 4,047.13%6.25M | 1,158.53%3.9M | -4,483.73%-748.43K | 82.10%-519.05K |
| Asset deal income | -31.93%2.92M | 88.87%4.15M | 8,325.02%4.3M | 2,122.50%4.04M | 7,378.27%4.29M | -90.83%2.2M | -100.23%-52.3K | -98.99%181.66K | -100.33%-58.97K | -60.41%23.97M |
| Other revenue | 24.70%7.55M | -22.20%30.65M | -35.04%20.06M | -41.53%14.06M | -0.51%6.05M | 36.97%39.4M | 129.76%30.89M | 175.16%24.05M | 76.14%6.08M | 85.88%28.76M |
| Operating profit | 4.33%274.94M | 1.58%1.02B | 2.24%771.61M | 1.90%545.53M | 4.52%263.54M | 7.83%1.01B | 7.17%754.69M | 12.24%535.37M | 18.56%252.13M | 10.48%934.32M |
| Add:Non operating Income | 113.16%7.72M | 383.59%12.41M | 254.62%8.42M | 395.78%7.92M | 1,100.45%3.62M | -68.17%2.57M | -31.79%2.37M | -49.15%1.6M | -79.72%301.59K | -52.50%8.06M |
| Less:Non operating expense | 27.87%6.33M | 1.50%32.42M | -29.79%17.47M | -18.70%12.56M | -33.08%4.95M | -12.18%31.94M | -1.98%24.89M | -17.27%15.45M | 7.02%7.39M | 52.71%36.37M |
| Total profit | 5.39%276.34M | 2.59%1B | 4.15%762.55M | 3.71%540.88M | 7.01%262.22M | 7.95%978.07M | 7.31%732.18M | 13.01%521.52M | 18.24%245.04M | 8.00%906.01M |
| Less:Income tax cost | -6.92%60.75M | -1.88%260.28M | -0.23%198.75M | -1.64%143.34M | 6.23%65.27M | 39.54%265.26M | 57.25%199.22M | 104.29%145.73M | 11.04%61.44M | -16.74%190.09M |
| Add:Adjusted items effecting net profit | ---0.01 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net profit | 9.46%215.58M | 4.25%743.12M | 5.79%563.81M | 5.79%397.54M | 7.27%196.95M | -0.43%712.81M | -4.07%532.96M | -3.68%375.79M | 20.86%183.61M | 17.26%715.92M |
| Net profit from continuing operation | 9.46%215.58M | 4.25%743.12M | 5.79%563.81M | 5.79%397.54M | 7.27%196.95M | -0.43%712.81M | -4.07%532.96M | -3.68%375.79M | 20.86%183.61M | 17.26%715.92M |
| Less:Minority Profit | 0.95%38.22M | 27.79%172.49M | 31.57%121.92M | 28.41%86.22M | 9.92%37.86M | 12.25%134.98M | 8.55%92.67M | 17.98%67.15M | 77.93%34.45M | 14.12%120.25M |
| Net profit of parent company owners | 11.49%177.36M | -1.25%570.63M | 0.36%441.88M | 0.87%311.32M | 6.65%159.08M | -3.00%577.83M | -6.37%440.3M | -7.38%308.64M | 12.53%149.16M | 17.91%595.67M |
| Earning per share | ||||||||||
| Basic earning per share | 9.76%0.135 | -1.57%0.438 | 0.00%0.34 | 1.27%0.24 | 7.89%0.123 | -6.32%0.445 | -10.53%0.34 | -14.13%0.237 | 1.79%0.114 | -2.06%0.475 |
| Diluted earning per share | 9.76%0.135 | -1.57%0.438 | 0.00%0.34 | 1.27%0.24 | 7.89%0.123 | -6.32%0.445 | -10.53%0.34 | -14.13%0.237 | 1.79%0.114 | -2.06%0.475 |
| Other composite income | -16.05%-7.23M | 69.49%12.77M | 459.86%28.16M | -186.80%-7.7M | -135.62%-6.23M | 113.97%7.54M | 108.18%5.03M | 125.46%8.87M | 156.65%17.49M | -21.67%-53.96M |
| Other composite income of parent company owners | -15.63%-6.88M | 62.26%12.57M | 405.93%27.16M | -191.04%-8.11M | -134.36%-5.95M | 114.72%7.75M | 108.91%5.37M | 124.96%8.91M | 156.21%17.31M | -25.84%-52.65M |
| Other composite income of minority owners | -24.89%-351.1K | 194.21%200.11K | 394.27%997.38K | 1,145.38%411.49K | -260.28%-281.13K | 83.75%-212.41K | 72.72%-338.93K | -104.61%-39.36K | 335.03%175.4K | 47.92%-1.31M |
| Total composite income | 9.25%208.35M | 4.93%755.89M | 10.03%591.96M | 1.35%389.85M | -5.16%190.72M | 8.82%720.35M | 8.88%537.99M | 8.26%384.66M | 66.14%201.09M | 16.91%661.96M |
| Total composite income of parent company owners | 11.33%170.48M | -0.41%583.2M | 5.25%469.04M | -4.52%303.21M | -8.01%153.13M | 7.84%585.57M | 8.70%445.66M | 6.73%317.55M | 63.60%166.47M | 17.20%543.02M |
| Total composite income of minority owners | 0.77%37.87M | 28.14%172.69M | 33.13%122.92M | 29.09%86.63M | 8.55%37.58M | 13.31%134.77M | 9.76%92.33M | 16.17%67.11M | 79.53%34.62M | 15.64%118.94M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) | -- | -- | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) | -- | -- | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.